Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Could Slip 5% On Lower Margins
Seeking Alpha
Friday, May 25, 2012 - 10:02am
tags:
JNJ
EU body wants new guidance on Boehringer clot drug
Reuters
Friday, May 25, 2012 - 10:01am
tags:
bloodthinners, Pradaxa, Boehringer Ingelheim, Europe, EMA
U.S. Senate passes bipartisan FDA funding bill
Reuters
Friday, May 25, 2012 - 10:01am
tags:
Senate, FDA, PDUFA
Takeda chases emerging market sales with Brazil buy
Reuters
Friday, May 25, 2012 - 9:57am
tags:
Takeda, M&A, Brazil, Multilab
The Medicare Drug 'Donut Hole' is a Much Smaller Problem Than You Think
Forbes
Friday, May 25, 2012 - 9:56am
tags:
Medicare
FDA Nod for Merck Drug Label Update
Yahoo/Zacks.com
Friday, May 25, 2012 - 9:52am
tags:
Merck, Isentress, HIV, FDA
As The Senate Vote On PDUFA Finally Nears…
Pharmalot
Thursday, May 24, 2012 - 12:54pm
tags:
Senate, PDUFA, drug approvals, FDA, biosimilars
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thursday, May 24, 2012 - 12:53pm
tags:
ASCO, Eli Lilly, Galena Biopharma, Dendreon, Exelixis, CytRx, Array Biopharma, Ariad Pharmaceuticals
Vertex falls after analyst expresses doubt about cystic fibrosis drug
The Fly on the Wall
Thursday, May 24, 2012 - 12:51pm
tags:
Vertex Pharmaceuticals, cystic fibrosis, Kalydeco, VX-809
Novartis: The Market Is Wrong About This Pharma Stock
Seeking Alpha
Thursday, May 24, 2012 - 12:50pm
tags:
Novartis
Johnson & Johnson Setback Is Positive for Pfizer, Bristol-Myers
Minyanville
Thursday, May 24, 2012 - 12:49pm
tags:
Pfizer, JNJ, Bristol-Myers Squibb, Xarelto, bloodthinners
Shanghai Pharma Denies Probe Report, Says Deals Complied
Bloomberg
Thursday, May 24, 2012 - 10:35am
tags:
Shanghai Pharmaceutical
Pfizer Launches Lipitor Mobile App
Marketing Daily
Thursday, May 24, 2012 - 10:34am
tags:
Pfizer, Lipitor, mobile apps
Glaxo Avoids Market For Lemons By Buying Collaborators
Bloomberg
Thursday, May 24, 2012 - 10:27am
tags:
GSK, M&A, Human Genome Sciences, Theravance, diaDexus
Breathe Deeply: Safety Concerns Over Spiriva
Pharmalot
Thursday, May 24, 2012 - 10:15am
tags:
Spiriva, Boehringer Ingelheim, COPD
Zalicus Is Locked And Loaded: What You Need To Know
Seeking Alpha
Thursday, May 24, 2012 - 10:14am
tags:
Zalicus, Synavive, rheumatoid arthritis
Teva Pharm cuts 2012 sales, profit outlook
Reuters
Thursday, May 24, 2012 - 10:13am
tags:
Teva Pharmaceuticals, guidance
Nexavar: Are 3 Failed Phase 3 Trials Enough?
Motley Fool
Thursday, May 24, 2012 - 10:13am
tags:
Bayer, Onyx, Nexavar, lung cancer
Eli Lilly announces Phase 3 study results for linagliptin
The Fly on the Wall
Thursday, May 24, 2012 - 10:01am
tags:
Eli Lilly, linagliptin, diabetes
J&J's Xarelto likely delayed 3-12 months, not dead, says Leerink
The Fly on the Wall
Thursday, May 24, 2012 - 9:43am
tags:
bloodthinner, JNJ, Xarelto

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.